rs2244008

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000426.4(LAMA2):​c.7906A>G​(p.Thr2636Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0722 in 1,605,722 control chromosomes in the GnomAD database, including 4,812 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T2636T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.087 ( 631 hom., cov: 32)
Exomes 𝑓: 0.071 ( 4181 hom. )

Consequence

LAMA2
NM_000426.4 missense

Scores

3
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 3.99

Publications

30 publications found
Variant links:
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
LAMA2 Gene-Disease associations (from GenCC):
  • congenital merosin-deficient muscular dystrophy 1A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
  • LAMA2-related muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy, limb-girdle, autosomal recessive 23
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020777285).
BP6
Variant 6-129491908-A-G is Benign according to our data. Variant chr6-129491908-A-G is described in ClinVar as Benign. ClinVar VariationId is 92989.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.155 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA2NM_000426.4 linkc.7906A>G p.Thr2636Ala missense_variant Exon 57 of 65 ENST00000421865.3 NP_000417.3
LAMA2NM_001079823.2 linkc.7894A>G p.Thr2632Ala missense_variant Exon 56 of 64 NP_001073291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA2ENST00000421865.3 linkc.7906A>G p.Thr2636Ala missense_variant Exon 57 of 65 5 NM_000426.4 ENSP00000400365.2

Frequencies

GnomAD3 genomes
AF:
0.0875
AC:
13305
AN:
152096
Hom.:
634
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.113
Gnomad AMI
AF:
0.0888
Gnomad AMR
AF:
0.0737
Gnomad ASJ
AF:
0.0833
Gnomad EAS
AF:
0.164
Gnomad SAS
AF:
0.114
Gnomad FIN
AF:
0.112
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0638
Gnomad OTH
AF:
0.0824
GnomAD2 exomes
AF:
0.0872
AC:
21834
AN:
250466
AF XY:
0.0862
show subpopulations
Gnomad AFR exome
AF:
0.112
Gnomad AMR exome
AF:
0.0733
Gnomad ASJ exome
AF:
0.0855
Gnomad EAS exome
AF:
0.182
Gnomad FIN exome
AF:
0.113
Gnomad NFE exome
AF:
0.0672
Gnomad OTH exome
AF:
0.0751
GnomAD4 exome
AF:
0.0706
AC:
102602
AN:
1453508
Hom.:
4181
Cov.:
31
AF XY:
0.0711
AC XY:
51460
AN XY:
723670
show subpopulations
African (AFR)
AF:
0.109
AC:
3622
AN:
33270
American (AMR)
AF:
0.0704
AC:
3146
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.0855
AC:
2230
AN:
26078
East Asian (EAS)
AF:
0.163
AC:
6433
AN:
39580
South Asian (SAS)
AF:
0.0890
AC:
7659
AN:
86066
European-Finnish (FIN)
AF:
0.114
AC:
6104
AN:
53396
Middle Eastern (MID)
AF:
0.0601
AC:
346
AN:
5756
European-Non Finnish (NFE)
AF:
0.0619
AC:
68356
AN:
1104540
Other (OTH)
AF:
0.0783
AC:
4706
AN:
60128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
4341
8682
13023
17364
21705
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2638
5276
7914
10552
13190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0874
AC:
13302
AN:
152214
Hom.:
631
Cov.:
32
AF XY:
0.0906
AC XY:
6745
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.113
AC:
4691
AN:
41542
American (AMR)
AF:
0.0737
AC:
1127
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0833
AC:
289
AN:
3470
East Asian (EAS)
AF:
0.164
AC:
848
AN:
5174
South Asian (SAS)
AF:
0.112
AC:
539
AN:
4814
European-Finnish (FIN)
AF:
0.112
AC:
1189
AN:
10598
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0638
AC:
4342
AN:
68006
Other (OTH)
AF:
0.0815
AC:
172
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
623
1246
1868
2491
3114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0723
Hom.:
1461
Bravo
AF:
0.0867
TwinsUK
AF:
0.0647
AC:
240
ALSPAC
AF:
0.0602
AC:
232
ESP6500AA
AF:
0.116
AC:
509
ESP6500EA
AF:
0.0630
AC:
542
ExAC
AF:
0.0879
AC:
10668
Asia WGS
AF:
0.119
AC:
412
AN:
3478
EpiCase
AF:
0.0632
EpiControl
AF:
0.0636

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Jan 28, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Merosin deficient congenital muscular dystrophy Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

LAMA2-related muscular dystrophy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital muscular dystrophy due to partial LAMA2 deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.033
.;T;T
Eigen
Benign
-0.0057
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.78
T;T;T
MetaRNN
Benign
0.0021
T;T;T
MetaSVM
Benign
-0.69
T
MutationAssessor
Benign
1.3
.;.;L
PhyloP100
4.0
PrimateAI
Benign
0.41
T
PROVEAN
Uncertain
-3.1
.;.;D
REVEL
Benign
0.27
Sift
Benign
0.035
.;.;D
Polyphen
0.015
.;.;B
Vest4
0.082
MPC
0.088
ClinPred
0.035
T
GERP RS
5.5
Varity_R
0.16
gMVP
0.45
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2244008; hg19: chr6-129813053; COSMIC: COSV70340957; API